Skip to main content
. 2015 Apr 16;32(6):893–902. doi: 10.1007/s10815-015-0474-6

Table 1.

Rare and novel sequence variants found by Sanger Sequencing and their respective bioinformatic analysis

Exonic DNA variants
Gene Patient DNA change (Location) Freq. Protein change Bioinformatic analysis
PolyPhen 2 SIFT HSF Mutation taster
CCDC39 3 (He) c.233G > A (exon 3) 0.56 % p.R78H Benign (s = 0.004) Tolerated (s = 0.28) No effect on Splice P (p = 0.90)
1 (He) c.2540A > G (exon 18) New variant p.E847G Benign (s = 0.165) Tolerated (s = 0.06) ESE (wt: 72.9 -mt: 82.9) Disease causing ( p= 0.69)
CCDC40 4 (He) c.2682G > A (exon 16) 0.61 % P (=) No effect on Splice P (p = 0.90)
Intronic DNA variants
Gene Patient DNA change (Location) Freq. Bioinformatic analysis
Splice Algorithms Mutation taster
CCDC40 3 (He) c.2620-92C > T (Intron 15) New variant No effect on Splice P (p = 0.9)
DNAH5 3 (Ho) c.1537-102 T > A (Intron11) ND No effect on Splice P (p = 0.9)
4 (Ho) c.1537-100_1537-99delTT (Intron 11) ND
1 (He)
1–4 (He) c.3835-3delT 0.1 % ↓ ASS Disease causing ( p= 1)
(intron24) nt:92.6 – mt:89.1 (SpliceSiteFinder-like)
nt:12.8 – mt:10.4 (MaxEntScan)
nt:11.9 – mt:9.8 (GeneSplicer)
nt:85.8– mt:85.3 (HSF)
3 (He) c.5882 + 133A > G (Intron 35) New variant No effect on Splice P (p = 0.9)
2 (Ho) 4,5 (He) c.7408-84_7408-83delAT (intron 44) ND
1 (He) c.10282-81delT (Intron60) ND
3 (He) c.10872 + 84 T > C (Intron63) ND
3 (He) c.11570 + 124G > C (Intron67) New variant
DNAH1 1 (He) c.81 + 61A > G 0.3 % ↑ ASS Disease causing ( P= 0.98)
(Intron2) wt:54.03/ mt:82.97; nt: 83.19(HSF)

Human Splice Finder (HSF): http://www.umd.be/HSF/; PolyPhen-2: http://genetics.bwh.harvard.edu/pph2/; SIFT: http://sift.jcvi.org; and the MutationTaster: http://www.mutationtaster.org/. Scores higher than 0.5 in Polyphen are considered damaging and in SIFT scores less than 0.05 are considered deleterious. In MutationTaster a probability (p) closer to 1 indicates a high confidence in the prediction. At bold are the variants with predict pathogenic impact

Freq. Frequency within control population (based on Exome variant server and SNP database from NCBI), He Heterozygous, Ho Homozygous, ND Variant listed in databases but with undetermined frequency on population, RArginine, HHistidine, EGlutamic acid, GGlycine, sscore, pprobability, PPolymorphism, ASS Acceptor Splice Site, wt reference score (i.e., the score of non-mutated sequence), mt mutant score (i.e., the score of mutated sequence), nt native splice site (i.e., normally occurring splice site), ESE Exonic Splice Enhancer